{"id":"NCT02462122","sponsor":"Bausch Health Americas, Inc.","briefTitle":"Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis","officialTitle":"A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-08-19","primaryCompletion":"2016-11-09","completion":"2016-11-14","firstPosted":"2015-06-03","resultsPosted":"2020-08-20","lastUpdate":"2020-08-20"},"enrollment":215,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"IDP-118 Lotion","otherNames":["Lotion"]},{"type":"DRUG","name":"IDP-118 Vehicle Lotion","otherNames":["Vehicle"]}],"arms":[{"label":"IDP-118 Lotion","type":"EXPERIMENTAL"},{"label":"IDP-118 Vehicle Lotion","type":"ACTIVE_COMPARATOR"}],"summary":"Safety and Efficacy of IDP-118 in the treatment of plaque psoriasis","primaryOutcome":{"measure":"The Percentage of Participants With Treatment Success at Week 8","timeFrame":"8 weeks","effectByArm":[{"arm":"IDP-118 Lotion","deltaMin":45.33,"sd":null},{"arm":"IDP-118 Vehicle Lotion","deltaMin":12.51,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":16,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":137},"commonTop":["Dermatitis contact","Pruritis"]}}